Conclusions and clinical implications Alcohol dependence is a chronic, relapsing, and incurable disease that belongs to the most frequent psychiatric disorders. Personality disorder and chronicity constitute the essential different features of addiction severity and result in low abstinence rates of short- and medium-term therapies after extended

follow-up. A new understanding of alcoholism therapy recognizes alcohol Inhibitors,research,lifescience,medical dependence as a chronic disease such as hypertension, chronic polyarthritis, bronchial asthma, and diabetes mellitus. Similar to these diseases, alcohol dependence has to be treated with an unusually intensive biopsychosocial approach. Only comprehensive, integrated, Inhibitors,research,lifescience,medical and structured long-term therapy with a strict abstinence orientation, followed by lifelong attending of checkup sessions and self-help group participation will guarantee long-term recovery. OLITA shows a 9-year abstinence rate of over 50%, a reemployment rate of 60%, and a dramatic recovery from comorbid depression, anxiety disorders, and physical sequelae. These outcome data are empirically based on treatment processes that have proven high predictive validity

and give Inhibitors,research,lifescience,medical concrete information about where to focus the therapeutic efforts. Thus, process-outcome research on OLITA can serve for the development of new therapeutic guidelines for adapting individual relapse prevention strategies. Selected abbreviations and acronyms HAQ Helping Inhibitors,research,lifescience,medical Alliance Questionnaire OLITA Outpatient Long-term Intensive Therapy for Alcoholics TOPPS Therapy Orientation by Process Prediction Score VAMP Video-Assisted Monitoring of Psychotherapeutic Processes in Chronic Psychiatric Disease
Cannabis sativa L. preparations, such as marijuana, hashish, and dagga, have been used in medicine for http://www.selleckchem.com/products/PD-0332991.html millenia.1 Investigations into the chemistry of Cannabis Inhibitors,research,lifescience,medical began in the mid-19th century, following a major trend in chemical research at the time, which centered on the quest for

active natural products. Numerous alkaloids were isolated in pure form or partially characterized. Morphine, cocaine, strychnine, Cilengitide and many others were purified and used in medicine. However, most of the terpenoids – a major class of secondary plant metabolites, to which the plant cannabinoids also belong – were not isolated until the end of the century or even much later, and in many cases their purity was doubtful. In 1840, Schlesinger was apparently the first investigator to obtain an active extract from the leaves and flowers of hemp.2 A few years later, Decourtive described the preparation of an ethanol extract that on evaporation of the solvent gave a dark resin, which he named “cannabin.” 3 For a detailed history of early Cannabis research see ref 4. The chemical research on the plant cannabinoids and their derivatives over nearly two centuries is described in ref 5.